Northwest Biotherapeutics (NWBO) Exchange Rate Effect (2010 - 2026)

Northwest Biotherapeutics' Exchange Rate Effect history runs 15 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• On a quarterly basis, Exchange Rate Effect rose 234.43% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 254.57% increase from a year earlier, with the FY2025 full-year figure at -$1.9 million, down 245.48% from the prior year.
• Exchange Rate Effect climbed to $2.2 million in Q1 2026 per NWBO's latest filing, from $561000.0 in the prior quarter.
• Across five years, Exchange Rate Effect topped out at $4.7 million in Q3 2022 and bottomed at -$3.9 million in Q2 2025.
• The 5-year median for Exchange Rate Effect is $561000.0 (2025), against an average of $386352.9.
• Across the five-year window, Exchange Rate Effect jumped 1509.38% in 2022 and plunged 22952.94% in 2025, its largest moves.
• Year by year, Exchange Rate Effect stood at -$2.8 million in 2022, then surged by 63.95% to -$1.0 million in 2023, then jumped by 451.78% to $3.6 million in 2024, then plunged by 84.21% to $561000.0 in 2025, then jumped by 287.7% to $2.2 million in 2026.
• Per Business Quant, the three latest NWBO Exchange Rate Effect figures stand at $2.2 million (Q1 2026), $561000.0 (Q4 2025), and $3.1 million (Q3 2025).